Vanda Marković-Peković

发表

Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

R. Banzi, M. Jakovljevic, B. Wettermark, 2021, BioMed research international.

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

A. Haycox, S. Simoens, B. Wettermark, 2018, Front. Public Health.

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

A. Haycox, S. Simoens, B. Godman, 2017, Frontiers in Pharmacology.

Utilisation of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study

S. Stoisavljević-Šatara, R. Škrbić, Vanda Marković-Peković, 2009, Pharmacoepidemiology and drug safety.

Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications

Z. Saleem, B. Godman, A. Saeed, 2021, Expert review of anti-infective therapy.

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

T. Cars, R. Malmström, L. Gustafsson, 2014, Front. Pharmacol..

Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications

B. Godman, A. Kurdi, Jurij Fürst, 2018, Front. Pharmacol..

Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future

R. Malmström, A. Vitry, B. Godman, 2015 .

Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications

E. Allocati, Vanda Marković-Peković, B. Tubić, 2021, Medicine access @ point of care.

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

A. Haycox, S. Simoens, B. Godman, 2016, Front. Pharmacol..

Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries

Z. Saleem, S. Campbell, J. Mwita, 2020, Expert review of pharmacoeconomics & outcomes research.

Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up

D. Vulić, B. Godman, S. Stoisavljević-Šatara, 2022, Frontiers in Pharmacology.

Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future

M. Bennie, B. Godman, V. Vlahović-Palčevski, 2016, Expert review of pharmacoeconomics & outcomes research.

Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions

L. Gustafsson, B. Godman, R. Škrbić, 2012, Expert review of pharmacoeconomics & outcomes research.

Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries

R. Banzi, B. Wettermark, B. Godman, 2022, Frontiers in Pharmacology.

The Expiry of Humira

I. Huys, E. Allocati, A. Vulto, 2021 .

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

I. Huys, E. Allocati, A. Vulto, 2020, Frontiers in Pharmacology.

Are pharmacists' good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries.

B. Godman, S. Bino, M. Oluka, 2018, Journal of global antimicrobial resistance.

Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina.

R. Škrbić, Vanda Marković-Peković, 2016, Vojnosanitetski pregled.

Self‐medication with antibiotics in the Republic of Srpska community pharmacies: pharmacy staff behavior

Vanda Marković-Peković, N. Grubiša, 2012, Pharmacoepidemiology and drug safety.

Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications

Z. Saleem, B. Godman, A. Saeed, 2022 .

Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications

B. Godman, Vanda Marković-Peković, J. Burger, 2017, Journal of research in pharmacy practice.

COVID-19, health care and self-medication issues in resource-limited settings: Findings and implications based on experiences in Ghana

Z. Saleem, B. Godman, D. Kibuule, 2021, Advances in Human Biology.

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future

S. Simoens, S. Jan, B. Godman, 2016, Front. Pharmacol..

Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA

A. Haycox, S. Simoens, S. Campbell, 2019, Expert review of pharmacoeconomics & outcomes research.

Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries

Z. Saleem, J. Mwita, B. Godman, 2021, Life.

Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia & Herzegovina

S. Stoisavljević-Šatara, R. Škrbić, Vanda Marković-Peković, 2010, European Journal of Clinical Pharmacology.

First experiences with the use of targeted and immunotherapy in the treatment of cutaneous melanoma: A single centre experience

Vanda Marković-Peković, B. Tubić, Z. Gojković, 2022, Scripta Medica.

Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future

Z. Saleem, S. Campbell, S. Jan, 2019, Current medical research and opinion.

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

M. A. Bakar, Z. Saleem, R. Banzi, 2021, Frontiers in Public Health.

Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

A. Haycox, S. Simoens, R. Malmström, 2013, Front. Pharmacol..

Evidence-based public policy making for medicines across countries: findings and implications for the future.

Z. Saleem, S. Campbell, E. Allocati, 2021, Journal of comparative effectiveness research.

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

Brian Godman, Samantha Alvarez-Madrazo, Stephen Campbell, 2014, Front. Pharmacol..

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

Steven Simoens, Bogdan Asanin, Vincent Hargaden, 2018, Front. Pharmacol..

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Steven Simoens, Brian Godman, Guenka Petrova, 2019, Generics and Biosimilars Initiative Journal.

Initiatives to reduce non-prescription sales and dispensing of antibiotics in the Republic of Srpska : findings and implications

B. Godman, Vanda Marković-Peković, J. Burger, 2017 .

The characteristics of the outpatient utilisation of medicines in the Republic of Srpska in the period 2009-2017

S. Stoisavljević-Šatara, Vanda Marković-Peković, L. Bojanić, 2019, Scripta Medica.

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

A. Haycox, S. Simoens, B. Godman, 2017, Front. Pharmacol..

Outpatient utilization of antibioticis in the Republic of Srpska, in 2007 and 2008

S. Stoisavljević-Šatara, Vanda Marković-Peković, 2010 .

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

S. Simoens, L. Gustafsson, J. Wale, 2021, Expert review of pharmacoeconomics & outcomes research.

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications

Panos Kanavos, Brian Godman, Guenka Petrova, 2017, PharmacoEconomics.

The first modern pharmacy in Banja Luka: The Brammer family, three generations of pharmacists

Vanda Marković-Peković, 2020 .

Public pharmacies on the territory of Bosnia and Herzegovina over the Austro-Hungarian rule

Vanda Marković-Peković, 2022, Scripta Medica.

JAVNE APOTEKE U SARAJEVU U AUSTROUGARSKOM PERIODU

Vanda Marković-Peković, 2020, ГЛАСНИК УДРУЖЕЊА АРХИВСКИХ РАДНИКА РЕПУБЛИКЕ СРПСКЕ.

Eleven-Year Trends in Lipid-Modifying Medicines Utilisation and Expenditure in a Low-Income Country: A Study from the Republic of Srpska, Bosnia and Herzegovina

D. Vulić, N. Divac, S. Stoisavljević-Šatara, 2023, ClinicoEconomics and outcomes research : CEOR.

Pharmacoepidemiological analysis of use of medicines prescribed on the account of the Republic of Srpska health insurance fund in the period of 2003-2004

S. Stoisavljević-Šatara, R. Škrbić, Vanda Marković-Peković, 2005 .

Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance

B. Godman, G. Rwegerera, C. Moore, 2023, Expert review of anti-infective therapy.

Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications

B. Godman, Vanda Marković-Peković, J. Burger, 2017, Journal of research in pharmacy practice.

Pilot study to evaluate the feasibility of a patient questionnaire for the purpose of investigating the extent of purchasing antibiotics without a prescription in a rural province in South Africa: Rationale and implications

J. Meyer, Vanda Marković-Peković, A. Jelić, 2024, Advances in Human Biology.

Potential strategies to limit inappropriate purchasing of antibiotics without a prescription in a rural province in South Africa: Pilot study and the implications

J. Meyer, Vanda Marković-Peković, A. Jelić, 2024, Advances in Human Biology.

Effective programmes to reduce inappropriate dispensing of antibiotics in community pharmacies especially in developing countries

Vanda Marković-Peković, Tiyani Milta Sono, Brian Godman, 2023, Advances in Human Biology.